Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

NCT02737046 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Adult T-cell Leukemia-Lymphoma
ATLL

Interventions

DRUG: Belinostat
DRUG: Zidovudine
DRUG: Interferon-Alfa-2b
DRUG: Pegylated Interferon-Alfa-2b
DRUG: Lymphodepleting Therapy

Sponsor

University of Miami